| Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy A Pauletti, G Terrone, T Shekh-Ahmad, A Salamone, T Ravizza, M Rizzi, ... Brain 142 (7), e39-e39, 2019 | 151 | 2019 |
| Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy A Pauletti, G Terrone, T Shekh-Ahmad, A Salamone, T Ravizza, M Rizzi, ... Brain, 2017 | 122 | 2017 |
| KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy T Shekh-Ahmad, R Eckel, S Dayalan Naidu, M Higgins, M Yamamoto, ... Brain 141 (5), 1390-1403, 2018 | 108 | 2018 |
| Epilepsy gene therapy using an engineered potassium channel A Snowball, E Chabrol, RC Wykes, T Shekh-Ahmad, JH Cornford, A Lieb, ... Journal of neuroscience 39 (16), 3159-3169, 2019 | 85 | 2019 |
| Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model AA Khan, T Shekh‐Ahmad, A Khalil, MC Walker, AB Ali British journal of pharmacology 175 (11), 2097-2115, 2018 | 79 | 2018 |
| Reactive oxygen species in status epilepticus T Shekh-Ahmad, S Kovac, AY Abramov, MC Walker Epilepsy & behavior 101, 106410, 2019 | 71 | 2019 |
| A new derivative of valproic acid amide possesses a broad‐spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage HS White, AB Alex, A Pollock, N Hen, T Shekh‐Ahmad, KS Wilcox, ... Epilepsia 53 (1), 134-146, 2012 | 69 | 2012 |
| Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy T Shekh-Ahmad, A Lieb, S Kovac, L Gola, WC Wigley, AY Abramov, ... Redox Biology 26, 101278, 2019 | 68 | 2019 |
| Approaches for reactive oxygen species and oxidative stress quantification in epilepsy R Olowe, S Sandouka, A Saadi, T Shekh-Ahmad Antioxidants 9 (10), 990, 2020 | 64 | 2020 |
| On-demand cell-autonomous gene therapy for brain circuit disorders Y Qiu, N O’Neill, B Maffei, C Zourray, A Almacellas-Barbanoj, ... Science 378 (6619), 523-532, 2022 | 39 | 2022 |
| A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus W Pouliot, M Bialer, N Hen, T Shekh-Ahmad, D Kaufmann, B Yagen, ... Neuroscience 231, 145-156, 2013 | 29 | 2013 |
| Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS‐active derivative of valproic acid with low teratogenic potential T Shekh‐Ahmad, N Hen, B Yagen, JH McDonough, RH Finnell, ... Epilepsia 55 (2), 353-361, 2014 | 26 | 2014 |
| Comparative steady‐state pharmacokinetic evaluation of immediate‐release topiramate and USL 255, a once‐daily extended‐release topiramate formulation M Bialer, T Shekh‐Ahmad, TL Braun, MB Halvorsen Epilepsia 54 (8), 1444-1452, 2013 | 25 | 2013 |
| Comparative pharmacokinetic analysis of USL255, a new once‐daily extended‐release formulation of topiramate LJ Lambrecht, T Shekh‐Ahmad, WM Todd, MB Halvorsen, M Bialer Epilepsia 52 (10), 1877-1883, 2011 | 24 | 2011 |
| sec‐Butyl‐propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon‐induced status epilepticus in rats G Bar‐Klein, E Swissa, L Kamintsky, T Shekh‐Ahmad, R Saar‐Ashkenazy, ... Epilepsia 55 (12), 1953-1958, 2014 | 22 | 2014 |
| Stereoselective Pharmacodynamic and Pharmacokinetic Analysis of sec-Butylpropylacetamide (SPD), a New CNS-Active Derivative of Valproic Acid with Unique … N Hen, T Shekh-Ahmad, B Yagen, JH McDonough, RH Finnell, ... Journal of Medicinal Chemistry 56 (16), 6467-6477, 2013 | 19 | 2013 |
| Induction of the Nrf2 pathway by sulforaphane is neuroprotective in a rat temporal lobe epilepsy model S Sandouka, T Shekh-Ahmad Antioxidants 10 (11), 1702, 2021 | 18 | 2021 |
| Valnoctamide and sec‐butyl‐propylacetamide (SPD) for acute seizures and status epilepticus T Shekh‐Ahmad, N Hen, JH McDonough, B Yagen, M Bialer Epilepsia 54, 99-102, 2013 | 18 | 2013 |
| The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus T Shekh-Ahmad, H Mawasi, JH McDonough, B Yagen, M Bialer Epilepsy & Behavior 49, 298-302, 2015 | 17 | 2015 |
| Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide—amide derivatives of valproic acid H Mawasi, T Shekh-Ahmad, RH Finnell, BJ Wlodarczyk, M Bialer Epilepsy & Behavior 46, 72-78, 2015 | 11 | 2015 |
